Variant report
Variant | esv3448810 |
---|---|
Chromosome Location | chr1:246672297-246672842 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:44)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:44 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BHLHE40 | chr1:246672265-246672773 | HepG2 | liver: | n/a | n/a |
2 | CTCF | chr1:246672245-246672467 | MCF-7 | breast: | n/a | n/a |
3 | CTCF | chr1:246672180-246672330 | GM12864 | blood: | n/a | n/a |
4 | CTCF | chr1:246672260-246672410 | HepG2 | liver: | n/a | n/a |
5 | CTCF | chr1:246672280-246672430 | GM12874 | blood: | n/a | n/a |
6 | CTCF | chr1:246672380-246672530 | GM12864 | blood: | n/a | n/a |
7 | CTCF | chr1:246672243-246672427 | HepG2 | liver: | n/a | n/a |
8 | CTCF | chr1:246672260-246672410 | Hela-S3 | cervix: | n/a | n/a |
9 | CTCF | chr1:246672339-246672358 | GM13976 | blood: | n/a | n/a |
10 | CTCF | chr1:246672245-246672470 | MCF-7 | breast: | n/a | n/a |
11 | CTCF | chr1:246672261-246672457 | MCF-7 | breast: | n/a | n/a |
12 | CTCF | chr1:246672232-246672495 | MCF-7 | breast: | n/a | n/a |
13 | CTCF | chr1:246672260-246672410 | SAEC | small airway: | n/a | n/a |
14 | CTCF | chr1:246672280-246672430 | SK-N-SH_RA | brain: | n/a | n/a |
15 | CTCF | chr1:246672316-246672442 | GM12891 | blood: | n/a | n/a |
16 | CTCF | chr1:246672300-246672363 | NHEK | skin: | n/a | n/a |
17 | CTCF | chr1:246672340-246672490 | MCF-7 | breast: | n/a | n/a |
18 | CTCF | chr1:246672323-246672371 | GM19238 | blood: | n/a | n/a |
19 | CTCF | chr1:246672240-246672390 | WERI-Rb-1 | eye: | n/a | n/a |
20 | CTCF | chr1:246672260-246672410 | GM12868 | blood: | n/a | n/a |
21 | CTCF | chr1:246672254-246672361 | Fibrobl | skin: | n/a | n/a |
22 | CTCF | chr1:246672260-246672410 | GM12870 | blood: | n/a | n/a |
23 | CTCF | chr1:246672272-246672433 | Hela-S3 | cervix: | n/a | n/a |
24 | CTCF | chr1:246672280-246672430 | GM12875 | blood: | n/a | n/a |
25 | CTCF | chr1:246672200-246672350 | A549 | lung: | n/a | n/a |
26 | CTCF | chr1:246672188-246672554 | MCF-7 | breast: | n/a | n/a |
27 | CTCF | chr1:246672260-246672410 | HRE | kidney: | n/a | n/a |
28 | CTCF | chr1:246672292-246672389 | GM12892 | blood: | n/a | n/a |
29 | CTCF | chr1:246672300-246672450 | GM12874 | blood: | n/a | n/a |
30 | CTCF | chr1:246672331-246672407 | Gliobla | brain: | n/a | n/a |
31 | CTCF | chr1:246672400-246672550 | SAEC | small airway: | n/a | n/a |
32 | CTCF | chr1:246672280-246672430 | HBMEC | blood vessel: | n/a | n/a |
33 | CTCF | chr1:246672022-246672662 | A549 | lung: | n/a | n/a |
34 | CTCF | chr1:246672660-246672810 | HepG2 | liver: | n/a | n/a |
35 | CTCF | chr1:246672221-246672478 | MCF-7 | breast: | n/a | n/a |
36 | CTCF | chr1:246672193-246672542 | MCF-7 | breast: | n/a | n/a |
37 | CTCF | chr1:246672317-246672374 | HepG2 | liver: | n/a | n/a |
38 | CTCF | chr1:246672460-246672610 | Hela-S3 | cervix: | n/a | n/a |
39 | CTCF | chr1:246672267-246672428 | A549 | lung: | n/a | n/a |
40 | CTCF | chr1:246672240-246672390 | MCF-7 | breast: | n/a | n/a |
41 | MAX | chr1:246672398-246672420 | HepG2 | liver: | n/a | n/a |
42 | MAZ | chr1:246672389-246672535 | Hela-S3 | cervix: | n/a | n/a |
43 | RAD21 | chr1:246672235-246672424 | HepG2 | liver: | n/a | n/a |
44 | RAD21 | chr1:246672280-246672420 | HepG2 | liver: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
SMYD3 | TF binding region |
ENSG00000162852 | chromatin interactions |
ENSG00000162851 | chromatin interactions |
ENSG00000185420 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs61839848 | chr1:246672307-246672308 | Weak transcription ZNF genes & repeats Bivalent/Poised TSS Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs550954101 | chr1:246672336-246672337 | Weak transcription ZNF genes & repeats Bivalent/Poised TSS Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
3 | rs4081311 | chr1:246672337-246672338 | Weak transcription ZNF genes & repeats Bivalent/Poised TSS Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs187311735 | chr1:246672351-246672352 | Weak transcription ZNF genes & repeats Bivalent/Poised TSS Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
5 | rs546865189 | chr1:246672383-246672384 | Weak transcription ZNF genes & repeats Bivalent/Poised TSS Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
6 | rs566689830 | chr1:246672399-246672400 | Weak transcription ZNF genes & repeats Bivalent/Poised TSS Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs538808396 | chr1:246672400-246672401 | Weak transcription ZNF genes & repeats Bivalent/Poised TSS Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
8 | rs551393512 | chr1:246672418-246672419 | Weak transcription ZNF genes & repeats Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
9 | rs192209789 | chr1:246672455-246672456 | Weak transcription ZNF genes & repeats Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
10 | rs537548527 | chr1:246672464-246672465 | Weak transcription ZNF genes & repeats Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
11 | rs554288509 | chr1:246672465-246672466 | Weak transcription ZNF genes & repeats Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
12 | rs574363024 | chr1:246672471-246672472 | Weak transcription ZNF genes & repeats Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
13 | rs376988540 | chr1:246672488-246672489 | Weak transcription ZNF genes & repeats Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
14 | rs4040219 | chr1:246672503-246672504 | Weak transcription ZNF genes & repeats Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs576772111 | chr1:246672508-246672509 | Weak transcription ZNF genes & repeats Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
16 | rs142527672 | chr1:246672586-246672587 | Weak transcription ZNF genes & repeats Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
17 | rs559973760 | chr1:246672641-246672642 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
18 | rs371480596 | chr1:246672688-246672689 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
19 | rs573479984 | chr1:246672698-246672699 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
20 | rs545584763 | chr1:246672712-246672713 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
21 | rs114039624 | chr1:246672719-246672720 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
22 | rs530980969 | chr1:246672720-246672721 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
23 | rs544716223 | chr1:246672721-246672722 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
24 | rs75525164 | chr1:246672739-246672740 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
25 | rs530092384 | chr1:246672748-246672749 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
26 | rs546708204 | chr1:246672757-246672758 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
27 | rs78148537 | chr1:246672776-246672777 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
28 | rs2152887 | chr1:246672790-246672791 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs115562670 | chr1:246672797-246672798 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
30 | rs567907794 | chr1:246672809-246672810 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
31 | rs535231818 | chr1:246672813-246672814 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Liposarcoma | 21253554 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 21549014 | CNVD |
Mental retardation | 21549014 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 17060936 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Disease | 21936942 | CNVD |
laryngomalacia | 21936942 | CNVD |
GLUT3 deficiency syndrome | 20509907 | CNVD |
Developmental delay | 21373258 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Developmental delay | 19490664 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Cutaneous malignant melanoma | 18794153 | CNVD |
Astrocytoma | 17934521 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Breast cancer | 20409316 | CNVD |
Fibroblasts | 17951408 | CNVD |
Lung cancer | 17951408 | CNVD |
Schizophrenia | 20967226 | CNVD |
Schizophrenia | 19805367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:246671200-246675000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
2 | chr1:246671200-246676000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr1:246672200-246672400 | Bivalent/Poised TSS | Foreskin Fibroblast Primary Cells skin02 | Skin |
4 | chr1:246672200-246672400 | Enhancers | Esophagus | oesophagus |
5 | chr1:246672200-246672400 | Enhancers | Fetal Stomach | stomach |
6 | chr1:246672200-246672400 | Enhancers | Stomach Smooth Muscle | stomach |
7 | chr1:246672200-246672400 | Flanking Active TSS | HepG2 | liver |
8 | chr1:246672200-246672600 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr1:246672400-246672600 | Enhancers | HepG2 | liver |
10 | chr1:246672600-246674400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr1:246672600-246675400 | Weak transcription | HepG2 | liver |